Enterome   Report issue

For profit Phase 1 Phase 2
Founded: Paris France (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2016
NCT02998190
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Enterome